Global Cancer Drug Therapy Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Cancer Drug Therapy Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Cancer Drug Therapy by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Cancer Drug Therapy by Country/Region, 2017, 2022 & 2028

2.2 Cancer Drug Therapy Segment by Type

2.2.1 Targeted Therapy

2.2.2 Chemotherapy

2.2.3 Immunotherapy

2.3 Cancer Drug Therapy Sales by Type

2.3.1 Global Cancer Drug Therapy Sales Market Share by Type (2017-2022)

2.3.2 Global Cancer Drug Therapy Revenue and Market Share by Type (2017-2022)

2.3.3 Global Cancer Drug Therapy Sale Price by Type (2017-2022)

2.4 Cancer Drug Therapy Segment by Application

2.4.1 Angiogenesis Inhibitors

2.4.2 mTOR Inhibitors

2.4.3 Monoclonal Antibodies

2.4.4 Cytokine Immunotherapy (IL-2)

2.5 Cancer Drug Therapy Sales by Application

2.5.1 Global Cancer Drug Therapy Sale Market Share by Application (2017-2022)

2.5.2 Global Cancer Drug Therapy Revenue and Market Share by Application (2017-2022)

2.5.3 Global Cancer Drug Therapy Sale Price by Application (2017-2022)

3 Global Cancer Drug Therapy by Company

3.1 Global Cancer Drug Therapy Breakdown Data by Company

3.1.1 Global Cancer Drug Therapy Annual Sales by Company (2020-2022)

3.1.2 Global Cancer Drug Therapy Sales Market Share by Company (2020-2022)

3.2 Global Cancer Drug Therapy Annual Revenue by Company (2020-2022)

3.2.1 Global Cancer Drug Therapy Revenue by Company (2020-2022)

3.2.2 Global Cancer Drug Therapy Revenue Market Share by Company (2020-2022)

3.3 Global Cancer Drug Therapy Sale Price by Company

3.4 Key Manufacturers Cancer Drug Therapy Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Cancer Drug Therapy Product Location Distribution

3.4.2 Players Cancer Drug Therapy Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Cancer Drug Therapy by Geographic Region

4.1 World Historic Cancer Drug Therapy Market Size by Geographic Region (2017-2022)

4.1.1 Global Cancer Drug Therapy Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Cancer Drug Therapy Annual Revenue by Geographic Region

4.2 World Historic Cancer Drug Therapy Market Size by Country/Region (2017-2022)

4.2.1 Global Cancer Drug Therapy Annual Sales by Country/Region (2017-2022)

4.2.2 Global Cancer Drug Therapy Annual Revenue by Country/Region

4.3 Americas Cancer Drug Therapy Sales Growth

4.4 APAC Cancer Drug Therapy Sales Growth

4.5 Europe Cancer Drug Therapy Sales Growth

4.6 Middle East & Africa Cancer Drug Therapy Sales Growth

5 Americas

5.1 Americas Cancer Drug Therapy Sales by Country

5.1.1 Americas Cancer Drug Therapy Sales by Country (2017-2022)

5.1.2 Americas Cancer Drug Therapy Revenue by Country (2017-2022)

5.2 Americas Cancer Drug Therapy Sales by Type

5.3 Americas Cancer Drug Therapy Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Cancer Drug Therapy Sales by Region

6.1.1 APAC Cancer Drug Therapy Sales by Region (2017-2022)

6.1.2 APAC Cancer Drug Therapy Revenue by Region (2017-2022)

6.2 APAC Cancer Drug Therapy Sales by Type

6.3 APAC Cancer Drug Therapy Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Cancer Drug Therapy by Country

7.1.1 Europe Cancer Drug Therapy Sales by Country (2017-2022)

7.1.2 Europe Cancer Drug Therapy Revenue by Country (2017-2022)

7.2 Europe Cancer Drug Therapy Sales by Type

7.3 Europe Cancer Drug Therapy Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Cancer Drug Therapy by Country

8.1.1 Middle East & Africa Cancer Drug Therapy Sales by Country (2017-2022)

8.1.2 Middle East & Africa Cancer Drug Therapy Revenue by Country (2017-2022)

8.2 Middle East & Africa Cancer Drug Therapy Sales by Type

8.3 Middle East & Africa Cancer Drug Therapy Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Cancer Drug Therapy

10.3 Manufacturing Process Analysis of Cancer Drug Therapy

10.4 Industry Chain Structure of Cancer Drug Therapy

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Cancer Drug Therapy Distributors

11.3 Cancer Drug Therapy Customer

12 World Forecast Review for Cancer Drug Therapy by Geographic Region

12.1 Global Cancer Drug Therapy Market Size Forecast by Region

12.1.1 Global Cancer Drug Therapy Forecast by Region (2023-2028)

12.1.2 Global Cancer Drug Therapy Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Cancer Drug Therapy Forecast by Type

12.7 Global Cancer Drug Therapy Forecast by Application

13 Key Players Analysis

13.1 Amgen / Allergan

13.1.1 Amgen / Allergan Company Information

13.1.2 Amgen / Allergan Cancer Drug Therapy Product Offered

13.1.3 Amgen / Allergan Cancer Drug Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Amgen / Allergan Main Business Overview

13.1.5 Amgen / Allergan Latest Developments

13.2 Argos Therapeutics

13.2.1 Argos Therapeutics Company Information

13.2.2 Argos Therapeutics Cancer Drug Therapy Product Offered

13.2.3 Argos Therapeutics Cancer Drug Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Argos Therapeutics Main Business Overview

13.2.5 Argos Therapeutics Latest Developments

13.3 AstraZeneca

13.3.1 AstraZeneca Company Information

13.3.2 AstraZeneca Cancer Drug Therapy Product Offered

13.3.3 AstraZeneca Cancer Drug Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 AstraZeneca Main Business Overview

13.3.5 AstraZeneca Latest Developments

13.4 Aveo Pharmaceuticals

13.4.1 Aveo Pharmaceuticals Company Information

13.4.2 Aveo Pharmaceuticals Cancer Drug Therapy Product Offered

13.4.3 Aveo Pharmaceuticals Cancer Drug Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Aveo Pharmaceuticals Main Business Overview

13.4.5 Aveo Pharmaceuticals Latest Developments

13.5 Bayer

13.5.1 Bayer Company Information

13.5.2 Bayer Cancer Drug Therapy Product Offered

13.5.3 Bayer Cancer Drug Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Bayer Main Business Overview

13.5.5 Bayer Latest Developments

13.6 Exelixis

13.6.1 Exelixis Company Information

13.6.2 Exelixis Cancer Drug Therapy Product Offered

13.6.3 Exelixis Cancer Drug Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Exelixis Main Business Overview

13.6.5 Exelixis Latest Developments

13.7 Incyte

13.7.1 Incyte Company Information

13.7.2 Incyte Cancer Drug Therapy Product Offered

13.7.3 Incyte Cancer Drug Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Incyte Main Business Overview

13.7.5 Incyte Latest Developments

13.8 Merck

13.8.1 Merck Company Information

13.8.2 Merck Cancer Drug Therapy Product Offered

13.8.3 Merck Cancer Drug Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Merck Main Business Overview

13.8.5 Merck Latest Developments

13.9 Roche

13.9.1 Roche Company Information

13.9.2 Roche Cancer Drug Therapy Product Offered

13.9.3 Roche Cancer Drug Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Roche Main Business Overview

13.9.5 Roche Latest Developments

13.10 Bristol-Myers Squibb

13.10.1 Bristol-Myers Squibb Company Information

13.10.2 Bristol-Myers Squibb Cancer Drug Therapy Product Offered

13.10.3 Bristol-Myers Squibb Cancer Drug Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Bristol-Myers Squibb Main Business Overview

13.10.5 Bristol-Myers Squibb Latest Developments

13.11 Eisai

13.11.1 Eisai Company Information

13.11.2 Eisai Cancer Drug Therapy Product Offered

13.11.3 Eisai Cancer Drug Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Eisai Main Business Overview

13.11.5 Eisai Latest Developments

13.12 Exelixis

13.12.1 Exelixis Company Information

13.12.2 Exelixis Cancer Drug Therapy Product Offered

13.12.3 Exelixis Cancer Drug Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Exelixis Main Business Overview

13.12.5 Exelixis Latest Developments

13.13 Genentech (Roche)

13.13.1 Genentech (Roche) Company Information

13.13.2 Genentech (Roche) Cancer Drug Therapy Product Offered

13.13.3 Genentech (Roche) Cancer Drug Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Genentech (Roche) Main Business Overview

13.13.5 Genentech (Roche) Latest Developments

13.14 Novartis

13.14.1 Novartis Company Information

13.14.2 Novartis Cancer Drug Therapy Product Offered

13.14.3 Novartis Cancer Drug Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Novartis Main Business Overview

13.14.5 Novartis Latest Developments

13.15 Pfizer

13.15.1 Pfizer Company Information

13.15.2 Pfizer Cancer Drug Therapy Product Offered

13.15.3 Pfizer Cancer Drug Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Pfizer Main Business Overview

13.15.5 Pfizer Latest Developments

13.16 Prometheus Labs

13.16.1 Prometheus Labs Company Information

13.16.2 Prometheus Labs Cancer Drug Therapy Product Offered

13.16.3 Prometheus Labs Cancer Drug Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Prometheus Labs Main Business Overview

13.16.5 Prometheus Labs Latest Developments

14 Research Findings and Conclusion

Table 1. Cancer Drug Therapy Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Cancer Drug Therapy Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Targeted Therapy

Table 4. Major Players of Chemotherapy

Table 5. Major Players of Immunotherapy

Table 6. Global Cancer Drug Therapy Sales by Type (2017-2022) & (K Units)

Table 7. Global Cancer Drug Therapy Sales Market Share by Type (2017-2022)

Table 8. Global Cancer Drug Therapy Revenue by Type (2017-2022) & ($ million)

Table 9. Global Cancer Drug Therapy Revenue Market Share by Type (2017-2022)

Table 10. Global Cancer Drug Therapy Sale Price by Type (2017-2022) & (USD/Unit)

Table 11. Global Cancer Drug Therapy Sales by Application (2017-2022) & (K Units)

Table 12. Global Cancer Drug Therapy Sales Market Share by Application (2017-2022)

Table 13. Global Cancer Drug Therapy Revenue by Application (2017-2022)

Table 14. Global Cancer Drug Therapy Revenue Market Share by Application (2017-2022)

Table 15. Global Cancer Drug Therapy Sale Price by Application (2017-2022) & (USD/Unit)

Table 16. Global Cancer Drug Therapy Sales by Company (2020-2022) & (K Units)

Table 17. Global Cancer Drug Therapy Sales Market Share by Company (2020-2022)

Table 18. Global Cancer Drug Therapy Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Cancer Drug Therapy Revenue Market Share by Company (2020-2022)

Table 20. Global Cancer Drug Therapy Sale Price by Company (2020-2022) & (USD/Unit)

Table 21. Key Manufacturers Cancer Drug Therapy Producing Area Distribution and Sales Area

Table 22. Players Cancer Drug Therapy Products Offered

Table 23. Cancer Drug Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Cancer Drug Therapy Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Cancer Drug Therapy Sales Market Share Geographic Region (2017-2022)

Table 28. Global Cancer Drug Therapy Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Cancer Drug Therapy Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Cancer Drug Therapy Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Cancer Drug Therapy Sales Market Share by Country/Region (2017-2022)

Table 32. Global Cancer Drug Therapy Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Cancer Drug Therapy Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Cancer Drug Therapy Sales by Country (2017-2022) & (K Units)

Table 35. Americas Cancer Drug Therapy Sales Market Share by Country (2017-2022)

Table 36. Americas Cancer Drug Therapy Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Cancer Drug Therapy Revenue Market Share by Country (2017-2022)

Table 38. Americas Cancer Drug Therapy Sales by Type (2017-2022) & (K Units)

Table 39. Americas Cancer Drug Therapy Sales Market Share by Type (2017-2022)

Table 40. Americas Cancer Drug Therapy Sales by Application (2017-2022) & (K Units)

Table 41. Americas Cancer Drug Therapy Sales Market Share by Application (2017-2022)

Table 42. APAC Cancer Drug Therapy Sales by Region (2017-2022) & (K Units)

Table 43. APAC Cancer Drug Therapy Sales Market Share by Region (2017-2022)

Table 44. APAC Cancer Drug Therapy Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Cancer Drug Therapy Revenue Market Share by Region (2017-2022)

Table 46. APAC Cancer Drug Therapy Sales by Type (2017-2022) & (K Units)

Table 47. APAC Cancer Drug Therapy Sales Market Share by Type (2017-2022)

Table 48. APAC Cancer Drug Therapy Sales by Application (2017-2022) & (K Units)

Table 49. APAC Cancer Drug Therapy Sales Market Share by Application (2017-2022)

Table 50. Europe Cancer Drug Therapy Sales by Country (2017-2022) & (K Units)

Table 51. Europe Cancer Drug Therapy Sales Market Share by Country (2017-2022)

Table 52. Europe Cancer Drug Therapy Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Cancer Drug Therapy Revenue Market Share by Country (2017-2022)

Table 54. Europe Cancer Drug Therapy Sales by Type (2017-2022) & (K Units)

Table 55. Europe Cancer Drug Therapy Sales Market Share by Type (2017-2022)

Table 56. Europe Cancer Drug Therapy Sales by Application (2017-2022) & (K Units)

Table 57. Europe Cancer Drug Therapy Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Cancer Drug Therapy Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Cancer Drug Therapy Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Cancer Drug Therapy Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Cancer Drug Therapy Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Cancer Drug Therapy Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Cancer Drug Therapy Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Cancer Drug Therapy Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Cancer Drug Therapy Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Cancer Drug Therapy

Table 67. Key Market Challenges & Risks of Cancer Drug Therapy

Table 68. Key Industry Trends of Cancer Drug Therapy

Table 69. Cancer Drug Therapy Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Cancer Drug Therapy Distributors List

Table 72. Cancer Drug Therapy Customer List

Table 73. Global Cancer Drug Therapy Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Cancer Drug Therapy Sales Market Forecast by Region

Table 75. Global Cancer Drug Therapy Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Cancer Drug Therapy Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Cancer Drug Therapy Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Cancer Drug Therapy Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Cancer Drug Therapy Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Cancer Drug Therapy Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Cancer Drug Therapy Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Cancer Drug Therapy Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Cancer Drug Therapy Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Cancer Drug Therapy Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Cancer Drug Therapy Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Cancer Drug Therapy Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Cancer Drug Therapy Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Cancer Drug Therapy Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Cancer Drug Therapy Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Cancer Drug Therapy Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Cancer Drug Therapy Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Cancer Drug Therapy Revenue Market Share Forecast by Application (2023-2028)

Table 93. Amgen / Allergan Basic Information, Cancer Drug Therapy Manufacturing Base, Sales Area and Its Competitors

Table 94. Amgen / Allergan Cancer Drug Therapy Product Offered

Table 95. Amgen / Allergan Cancer Drug Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 96. Amgen / Allergan Main Business

Table 97. Amgen / Allergan Latest Developments

Table 98. Argos Therapeutics Basic Information, Cancer Drug Therapy Manufacturing Base, Sales Area and Its Competitors

Table 99. Argos Therapeutics Cancer Drug Therapy Product Offered

Table 100. Argos Therapeutics Cancer Drug Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 101. Argos Therapeutics Main Business

Table 102. Argos Therapeutics Latest Developments

Table 103. AstraZeneca Basic Information, Cancer Drug Therapy Manufacturing Base, Sales Area and Its Competitors

Table 104. AstraZeneca Cancer Drug Therapy Product Offered

Table 105. AstraZeneca Cancer Drug Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 106. AstraZeneca Main Business

Table 107. AstraZeneca Latest Developments

Table 108. Aveo Pharmaceuticals Basic Information, Cancer Drug Therapy Manufacturing Base, Sales Area and Its Competitors

Table 109. Aveo Pharmaceuticals Cancer Drug Therapy Product Offered

Table 110. Aveo Pharmaceuticals Cancer Drug Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 111. Aveo Pharmaceuticals Main Business

Table 112. Aveo Pharmaceuticals Latest Developments

Table 113. Bayer Basic Information, Cancer Drug Therapy Manufacturing Base, Sales Area and Its Competitors

Table 114. Bayer Cancer Drug Therapy Product Offered

Table 115. Bayer Cancer Drug Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 116. Bayer Main Business

Table 117. Bayer Latest Developments

Table 118. Exelixis Basic Information, Cancer Drug Therapy Manufacturing Base, Sales Area and Its Competitors

Table 119. Exelixis Cancer Drug Therapy Product Offered

Table 120. Exelixis Cancer Drug Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 121. Exelixis Main Business

Table 122. Exelixis Latest Developments

Table 123. Incyte Basic Information, Cancer Drug Therapy Manufacturing Base, Sales Area and Its Competitors

Table 124. Incyte Cancer Drug Therapy Product Offered

Table 125. Incyte Cancer Drug Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 126. Incyte Main Business

Table 127. Incyte Latest Developments

Table 128. Merck Basic Information, Cancer Drug Therapy Manufacturing Base, Sales Area and Its Competitors

Table 129. Merck Cancer Drug Therapy Product Offered

Table 130. Merck Cancer Drug Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 131. Merck Main Business

Table 132. Merck Latest Developments

Table 133. Roche Basic Information, Cancer Drug Therapy Manufacturing Base, Sales Area and Its Competitors

Table 134. Roche Cancer Drug Therapy Product Offered

Table 135. Roche Cancer Drug Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 136. Roche Main Business

Table 137. Roche Latest Developments

Table 138. Bristol-Myers Squibb Basic Information, Cancer Drug Therapy Manufacturing Base, Sales Area and Its Competitors

Table 139. Bristol-Myers Squibb Cancer Drug Therapy Product Offered

Table 140. Bristol-Myers Squibb Cancer Drug Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 141. Bristol-Myers Squibb Main Business

Table 142. Bristol-Myers Squibb Latest Developments

Table 143. Eisai Basic Information, Cancer Drug Therapy Manufacturing Base, Sales Area and Its Competitors

Table 144. Eisai Cancer Drug Therapy Product Offered

Table 145. Eisai Cancer Drug Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 146. Eisai Main Business

Table 147. Eisai Latest Developments

Table 148. Exelixis Basic Information, Cancer Drug Therapy Manufacturing Base, Sales Area and Its Competitors

Table 149. Exelixis Cancer Drug Therapy Product Offered

Table 150. Exelixis Cancer Drug Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 151. Exelixis Main Business

Table 152. Exelixis Latest Developments

Table 153. Genentech (Roche) Basic Information, Cancer Drug Therapy Manufacturing Base, Sales Area and Its Competitors

Table 154. Genentech (Roche) Cancer Drug Therapy Product Offered

Table 155. Genentech (Roche) Cancer Drug Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 156. Genentech (Roche) Main Business

Table 157. Genentech (Roche) Latest Developments

Table 158. Novartis Basic Information, Cancer Drug Therapy Manufacturing Base, Sales Area and Its Competitors

Table 159. Novartis Cancer Drug Therapy Product Offered

Table 160. Novartis Cancer Drug Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 161. Novartis Main Business

Table 162. Novartis Latest Developments

Table 163. Pfizer Basic Information, Cancer Drug Therapy Manufacturing Base, Sales Area and Its Competitors

Table 164. Pfizer Cancer Drug Therapy Product Offered

Table 165. Pfizer Cancer Drug Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 166. Pfizer Main Business

Table 167. Pfizer Latest Developments

Table 168. Prometheus Labs Basic Information, Cancer Drug Therapy Manufacturing Base, Sales Area and Its Competitors

Table 169. Prometheus Labs Cancer Drug Therapy Product Offered

Table 170. Prometheus Labs Cancer Drug Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 171. Prometheus Labs Main Business

Table 172. Prometheus Labs Latest Developments

List of Figures

Figure 1. Picture of Cancer Drug Therapy

Figure 2. Cancer Drug Therapy Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Cancer Drug Therapy Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Cancer Drug Therapy Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Cancer Drug Therapy Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Targeted Therapy

Figure 10. Product Picture of Chemotherapy

Figure 11. Product Picture of Immunotherapy

Figure 12. Global Cancer Drug Therapy Sales Market Share by Type in 2021

Figure 13. Global Cancer Drug Therapy Revenue Market Share by Type (2017-2022)

Figure 14. Cancer Drug Therapy Consumed in Angiogenesis Inhibitors

Figure 15. Global Cancer Drug Therapy Market: Angiogenesis Inhibitors (2017-2022) & (K Units)

Figure 16. Cancer Drug Therapy Consumed in mTOR Inhibitors

Figure 17. Global Cancer Drug Therapy Market: mTOR Inhibitors (2017-2022) & (K Units)

Figure 18. Cancer Drug Therapy Consumed in Monoclonal Antibodies

Figure 19. Global Cancer Drug Therapy Market: Monoclonal Antibodies (2017-2022) & (K Units)

Figure 20. Cancer Drug Therapy Consumed in Cytokine Immunotherapy (IL-2)

Figure 21. Global Cancer Drug Therapy Market: Cytokine Immunotherapy (IL-2) (2017-2022) & (K Units)

Figure 22. Global Cancer Drug Therapy Sales Market Share by Application (2017-2022)

Figure 23. Global Cancer Drug Therapy Revenue Market Share by Application in 2021

Figure 24. Cancer Drug Therapy Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Cancer Drug Therapy Revenue Market Share by Company in 2021

Figure 26. Global Cancer Drug Therapy Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Cancer Drug Therapy Revenue Market Share by Geographic Region in 2021

Figure 28. Global Cancer Drug Therapy Sales Market Share by Region (2017-2022)

Figure 29. Global Cancer Drug Therapy Revenue Market Share by Country/Region in 2021

Figure 30. Americas Cancer Drug Therapy Sales 2017-2022 (K Units)

Figure 31. Americas Cancer Drug Therapy Revenue 2017-2022 ($ Millions)

Figure 32. APAC Cancer Drug Therapy Sales 2017-2022 (K Units)

Figure 33. APAC Cancer Drug Therapy Revenue 2017-2022 ($ Millions)

Figure 34. Europe Cancer Drug Therapy Sales 2017-2022 (K Units)

Figure 35. Europe Cancer Drug Therapy Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Cancer Drug Therapy Sales 2017-2022 (K Units)

Figure 37. Middle East & Africa Cancer Drug Therapy Revenue 2017-2022 ($ Millions)

Figure 38. Americas Cancer Drug Therapy Sales Market Share by Country in 2021

Figure 39. Americas Cancer Drug Therapy Revenue Market Share by Country in 2021

Figure 40. United States Cancer Drug Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Cancer Drug Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Cancer Drug Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Cancer Drug Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Cancer Drug Therapy Sales Market Share by Region in 2021

Figure 45. APAC Cancer Drug Therapy Revenue Market Share by Regions in 2021

Figure 46. China Cancer Drug Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Cancer Drug Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Cancer Drug Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Cancer Drug Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Cancer Drug Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Cancer Drug Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Cancer Drug Therapy Sales Market Share by Country in 2021

Figure 53. Europe Cancer Drug Therapy Revenue Market Share by Country in 2021

Figure 54. Germany Cancer Drug Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Cancer Drug Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Cancer Drug Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Cancer Drug Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Cancer Drug Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Cancer Drug Therapy Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Cancer Drug Therapy Revenue Market Share by Country in 2021

Figure 61. Egypt Cancer Drug Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Cancer Drug Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Cancer Drug Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Cancer Drug Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Cancer Drug Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Cancer Drug Therapy in 2021

Figure 67. Manufacturing Process Analysis of Cancer Drug Therapy

Figure 68. Industry Chain Structure of Cancer Drug Therapy

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles